Neil Bodick

2017

In 2017, Neil Bodick earned a total compensation of $700.9K as Chief Scientific Officer and Co-Founder at Flexion Therapeutics, a 75% decrease compared to previous year.

Compensation breakdown

Bonus$248,400
Salary$413,462
Other$39,007
Total$700,869

Bodick received $413.5K in salary, accounting for 59% of the total pay in 2017.

Bodick also received $248.4K in bonus and $39K in other compensation.

Rankings

In 2017, Neil Bodick's compensation ranked 10,607th out of 14,666 executives tracked by ExecPay. In other words, Bodick earned more than 27.7% of executives.

ClassificationRankingPercentile
All
10,607
out of 14,666
28th
Division
Manufacturing
4,134
out of 5,772
28th
Major group
Chemicals And Allied Products
1,476
out of 2,075
29th
Industry group
Drugs
1,207
out of 1,731
30th
Industry
Pharmaceutical Preparations
938
out of 1,333
30th
Source: SEC filing on April 26, 2018.

Bodick's colleagues

We found three more compensation records of executives who worked with Neil Bodick at Flexion Therapeutics in 2017.

2017

Yamo Deniz

Flexion Therapeutics

Chief Medical Officer

2017

Mark Levine

Flexion Therapeutics

General Counsel

2017

Michael Clayman

Flexion Therapeutics

Chief Executive Officer

News

You may also like